200 related articles for article (PubMed ID: 30816486)
21. WW domain-containing E3 ubiquitin protein ligase 1 depletion evokes antitumor effect in cutaneous squamous cell carcinoma by inhibiting signal transducer and activator of transcription 3 signaling pathway.
Xia Y; Chang X; Lian S; Zhu W
J Int Med Res; 2018 Jul; 46(7):2898-2912. PubMed ID: 29888632
[TBL] [Abstract][Full Text] [Related]
22. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways.
Huang Y; Wang Y; Wang Y; Wang N; Duan Q; Wang S; Liu M; Bilal MA; Zheng Y
J Invest Dermatol; 2022 Feb; 142(2):303-313.e9. PubMed ID: 34358528
[TBL] [Abstract][Full Text] [Related]
23. Circular RNA expression in cutaneous squamous cell carcinoma.
Sand M; Bechara FG; Gambichler T; Sand D; Bromba M; Hahn SA; Stockfleth E; Hessam S
J Dermatol Sci; 2016 Sep; 83(3):210-8. PubMed ID: 27298156
[TBL] [Abstract][Full Text] [Related]
24. Role of miR-148a in cutaneous squamous cell carcinoma by repression of MAPK pathway.
Luo Q; Li W; Zhao T; Tian X; Liu Y; Zhang X
Arch Biochem Biophys; 2015 Oct; 583():47-54. PubMed ID: 26253263
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic Regulation of iASPP-p63 Feedback Loop in Cutaneous Squamous Cell Carcinoma.
Robinson DJ; Patel A; Purdie KJ; Wang J; Rizvi H; Hufbauer M; Ostano P; Akgül B; Chiorino G; Harwood CA; Bergamaschi D
J Invest Dermatol; 2019 Aug; 139(8):1658-1671.e8. PubMed ID: 30710576
[TBL] [Abstract][Full Text] [Related]
26. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
[TBL] [Abstract][Full Text] [Related]
27. Apigenin Induced Apoptosis by Downregulating Sulfiredoxin Expression in Cutaneous Squamous Cell Carcinoma.
Wang W; Liu X; Zhang Z; Yin M; Chen X; Zhao S; Wu L
Oxid Med Cell Longev; 2022; 2022():8172866. PubMed ID: 35965686
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways.
Chen H; Pan J; Zhang L; Chen L; Qi H; Zhong M; Shi X; Du J; Li Q
Eur J Pharmacol; 2018 Apr; 825():133-142. PubMed ID: 29476880
[TBL] [Abstract][Full Text] [Related]
29. CDC20 associated with cancer metastasis and novel mushroom‑derived CDC20 inhibitors with antimetastatic activity.
Cheng S; Castillo V; Sliva D
Int J Oncol; 2019 Jun; 54(6):2250-2256. PubMed ID: 31081056
[TBL] [Abstract][Full Text] [Related]
30. WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma.
Zimmerli D; Cecconi V; Valenta T; Hausmann G; Cantù C; Restivo G; Hafner J; Basler K; van den Broek M
Oncogene; 2018 Jul; 37(27):3753-3762. PubMed ID: 29662191
[TBL] [Abstract][Full Text] [Related]
31. The role of miRNAs in cutaneous squamous cell carcinoma.
Yu X; Li Z
J Cell Mol Med; 2016 Jan; 20(1):3-9. PubMed ID: 26508273
[TBL] [Abstract][Full Text] [Related]
32. NR5A2 promotes malignancy progression and mediates the effect of cisplatin in cutaneous squamous cell carcinoma.
Ye W; Ya-Xuan C; Shan-Shan T; Qiu L; Ting M; Shao-Jie C; Yu C
Immun Inflamm Dis; 2024 Feb; 12(2):e1172. PubMed ID: 38358044
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
34. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC.
Lohcharoenkal W; Harada M; Lovén J; Meisgen F; Landén NX; Zhang L; Lapins J; Mahapatra KD; Shi H; Nissinen L; Kähäri VM; Ståhle M; Sonkoly E; Grandér D; Arsenian-Henriksson M; Pivarcsi A
J Invest Dermatol; 2016 Dec; 136(12):2485-2494. PubMed ID: 27452220
[TBL] [Abstract][Full Text] [Related]
36. The Fgl2 interaction with Tyrobp promotes the proliferation of cutaneous squamous cell carcinoma by regulating ERK-dependent autophagy.
Zeng M; Li Q; Chen J; Huang W; Liu J; Wang C; Huang M; Li H; Zhou S; Xie M; Zeng K
Int J Med Sci; 2022; 19(1):195-204. PubMed ID: 34975313
[TBL] [Abstract][Full Text] [Related]
37. Epithelial-mesenchymal transition during invasion of cutaneous squamous cell carcinoma is paralleled by AKT activation.
Barrette K; Van Kelst S; Wouters J; Marasigan V; Fieuws S; Agostinis P; van den Oord J; Garmyn M
Br J Dermatol; 2014 Nov; 171(5):1014-21. PubMed ID: 24628329
[TBL] [Abstract][Full Text] [Related]
38. STMN1 overexpression correlates with biological behavior in human cutaneous squamous cell carcinoma.
Li X; Wang L; Li T; You B; Shan Y; Shi S; Qian L; Cao X
Pathol Res Pract; 2015 Nov; 211(11):816-23. PubMed ID: 26235036
[TBL] [Abstract][Full Text] [Related]
39. Maspin suppresses growth, proliferation and invasion in cutaneous squamous cell carcinoma cells.
Zhu H; Mao Q; Liu W; Yang Z; Jian X; Qu L; He C
Oncol Rep; 2017 May; 37(5):2875-2882. PubMed ID: 28405681
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptors -4 and -5 in oral and cutaneous squamous cell carcinomas.
Omar AA; Korvala J; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Rihtniemi J; Pihakari A; Sorsa T; Hagström J; Salo T
J Oral Pathol Med; 2015 Apr; 44(4):258-65. PubMed ID: 25047824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
